Microbix Biosystems Inc.
MBX.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.68M | 11.96M | 13.26M | 15.15M | 16.34M |
| Total Other Revenue | -- | -- | -- | 0.00 | 0.00 |
| Total Revenue | 10.68M | 11.96M | 13.26M | 15.15M | 16.34M |
| Cost of Revenue | 6.14M | 6.39M | 6.24M | 6.71M | 6.91M |
| Gross Profit | 4.54M | 5.58M | 7.01M | 8.44M | 9.43M |
| SG&A Expenses | 6.40M | 6.39M | 6.35M | 6.25M | 6.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.25M | 14.42M | 14.26M | 14.60M | 14.73M |
| Operating Income | -3.57M | -2.46M | -1.01M | 552.30K | 1.61M |
| Income Before Tax | -4.17M | -3.13M | -1.68M | -127.50K | 1.24M |
| Income Tax Expenses | -40.50K | -40.50K | -40.50K | 110.40K | 110.40K |
| Earnings from Continuing Operations | -4.13 | -3.09 | -1.64 | -0.24 | 1.13 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.13M | -3.09M | -1.64M | -237.90K | 1.13M |
| EBIT | -3.57M | -2.46M | -1.01M | 552.30K | 1.61M |
| EBITDA | -2.39M | -1.31M | 194.00K | 1.54M | 2.59M |
| EPS Basic | -0.03 | -0.02 | -0.01 | 0.00 | 0.01 |
| Normalized Basic EPS | -0.02 | -0.01 | -0.01 | 0.00 | 0.01 |
| EPS Diluted | -0.03 | -0.02 | -0.01 | 0.00 | 0.01 |
| Normalized Diluted EPS | -0.02 | -0.01 | -0.01 | 0.00 | 0.01 |
| Average Basic Shares Outstanding | 554.52M | 555.70M | 551.56M | 555.65M | 551.91M |
| Average Diluted Shares Outstanding | 554.60M | 556.50M | 552.99M | 557.83M | 554.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |